Mergers & Acquisitions - Respiratory and Pulmonary, Research

Filter

Popular Filters

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

06-05-2014

Confirming strong rumors over the past week or so, German pharma major Bayer confirmed it has agreed…

AdempasBayerLicensingMerck & CoMergers & AcquisitionsPharmaceuticalResearchRespiratory and Pulmonaryvericiguat

Valeant pulls out of deal with ISTA, which announces Beposone progress

31-01-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has withdrawn…

BeposoneISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalResearchRespiratory and PulmonaryValeant Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top